Skip to main content
. Author manuscript; available in PMC: 2025 Apr 1.
Published in final edited form as: Ann Thorac Surg. 2023 Jun 3;117(4):725–732. doi: 10.1016/j.athoracsur.2023.04.046

Table 3:

Post-transplant outcomes and causes of death of lung transplant recipients, 2005-2020.

Variable, n (%) 18-59 years
N=13,228
60-69 years
N=12,282
≥70 years
N=2,448
p-value
ECMO within 72 hours 557 (9.0%) 374 (5.7%) 79 (4.9%) <0.001
Acute rejection 1,213 (9.2%) 914 (7.4%) 163 (6.7%) <0.001
Post-operative dialysis 1,006 (7.6%) 738 (6.0%) 127 (5.2%) <0.001
Hospital LOS (days), median (IQR) 17 (12-29) 16 (11-28) 16 (11-27) <0.001
Intubation at 72 hours 2,144 (34.5%) 1,814 (27.4%) 353 (21.7%) <0.001
Treated for rejection within 1 year 3,054 (26.7%) 2,467 (23.6%) 442 (21.7%) <0.001
Cause of death by 1 year <0.001
 Infection 345 (24.5%) 469 (28.4%) 102 (25.6%)
 Hemorrhage 209 (14.8%) 257 (15.6%) 76 (19.1%)
 Pulmonary 212 (15.0%) 253 (15.3%) 66 (16.6%)
 Cardiovascular 136 (9.6%) 180 (10.9%) 49 (12.3%)
 Malignancy 34 (2.4%) 63 (3.8%) 25 (6.3%)
 Graft Failure – other 129 (9.1%) 104 (6.3%) 18 (4.5%)
 Cerebrovascular 101 (7.2%) 100 (6.1%) 14 (3.5%)
 Graft Failure – rejection 74 (5.2%) 61 (3.7%) 11 (2.8%)
 Renal Failure 2 (0.1%) 13 (0.8%) 4 (1.0%)
 Other 169 (12.0%) 151 (9.1%) 33 (8.3%)
Cause of death by 5 years <0.001
 Infection 785 (18.7%) 1,050 (22.3%) 210 (18.9%)
 Pulmonary 907 (21.6%) 857 (18.2%) 210 (18.9%)
 Hemorrhage 569 (13.5%) 694 (14.7%) 189 (17.0%)
 Malignancy 233 (5.5%) 499 (10.6%) 161 (14.5%)
 Cardiovascular 246 (5.8%) 369 (7.8%) 107 (9.6%)
 Graft Failure – rejection 745 (17.7%) 588 (12.5%) 97 (8.7%)
 Graft Failure – other 210 (5.0%) 171 (3.6%) 34 (3.1%)
 Cerebrovascular 151 (3.6%) 156 (3.3%) 26 (2.3%)
 Renal Failure 36 (0.9%) 62 (1.3%) 14 (1.3%)
 Other 326 (7.7%) 262 (5.6%) 66 (5.9%)

ECMO, extracorporeal membrane oxygenation; LOS, length of stay; IQR, interquartile range.